Mielóma multiplex: vizsgálatok itt: Dánia
26 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleBispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients
- Where
- Copenhagen, Odense, Vejle
- Életkor
- 18 év to 70 év
- People
- 50 worldwide
- Run by
- North Estonia Medical Centre
See details and how to joinNCT06505369